RAPTOR PHARMACEUTICALS
Raptor Pharmaceuticals Corp. operates as a development stage biotechnology company in the United States. The company engages in the discovery, research, and preclinical development of drug candidates and drug-targeting platforms for the treatment of various brain disorders and neurodegenerative diseases, genetic disorders, and cancer through the proprietary use of receptor-associated proteins and mesoderm development proteins. Its clinical-stage products include DR Cysteamine, which is in Phase ... IIb clinical trail for the treatment of nephropathic cystinosis or cystinosis; and in Phase IIa clinical trail for the treatment of non-alcoholic steatohepatitis. The company also develops Convivia, a Phase IIa clinical trail product for the treatment of aldehyde dehydrogenase or ALDH2 deficiency; DR Cysteamine, which is in Phase II clinical trail for the treatment of Huntington's Disease; and Tezampanel and NGX 426 that is in Phase II clinical trail for the treatment of migraine, acute pain, and chronic pain. In addition, its preclinical development products comprise HepTide for the treatment of Hepatocellular Carcinoma and Hepatitis C; WntTide for the treatment of breast cancer; and NeuroTrans for the treatment of neurodegenerative diseases. The company has collaboration agreements with the University of California, San Diego for a clinical study of DR Cysteamine in juvenile patients with Non-Alcoholic Steatohepatitis and to study DR Cysteamine in patients with cystinosis. Raptor Pharmaceuticals Corp was founded in 2005 and is based in Novato, California.
RAPTOR PHARMACEUTICALS
Industry:
Biopharma Biotechnology Genetics Therapeutics
Founded:
2002-04-01
Address:
Novato, California, United States
Country:
United States
Website Url:
http://www.raptorpharma.com
Total Employee:
51+
Status:
Active
Contact:
4153828002
Email Addresses:
[email protected]
Total Funding:
172.89 M USD
Technology used in webpage:
SPF Google Tag Manager Domain Not Resolving Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS JQuery CDN Apache 2.4 Sectigo SSL Sectigo Domain SSL
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Civitas Therapeutics
Civitas Therapeutics is a biopharmaceutical company that focuses on developing pulmonary delivery therapies.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2009-09-29 | TorreyPines Therapeutics | TorreyPines Therapeutics acquired by Raptor Pharmaceuticals | N/A |
Investors List
HealthCare Royalty Partners
HealthCare Royalty Partners investment in Post-IPO Debt - Raptor Pharmaceuticals
Heights Capital Management
Heights Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Iroquois Capital
Iroquois Capital investment in Post-IPO Equity - Raptor Pharmaceuticals
Deerfield Capital Management
Deerfield Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Dafna Capital Management
Dafna Capital Management investment in Post-IPO Equity - Raptor Pharmaceuticals
Lincoln Park Capital Fund
Lincoln Park Capital Fund investment in Post-IPO Equity - Raptor Pharmaceuticals
Official Site Inspections
http://www.raptorpharma.com
- Host name: 206.176.233.40
- IP address: 206.176.233.40
- Location: Petaluma United States
- Latitude: 38.2478
- Longitude: -122.6192
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94954